Is a complete NSE/ARTEMISMED research report available?

No complete published report is available for nse/ARTEMISMED (NSE/ARTEMISMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/ARTEMISMED stock profile: metrics, valuation and analysis

Market cap	54.6B
Revenue (ttm)	11.1B
Net income (ttm)	1.1B
EPS (ttm)	₹7.19
Shares out	158.3M
P/E (trailing)	48.0x
P/E (forward)	37.5x
Dividend	₹0.45 (0.14%)
Volume	347,086
Beta	0.32

All NSE/ARTEMISMED indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

INR

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2,055
Employees Change	-22%
Employees Change Percent	-1.06
Enterprise value	INR 56.9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	73.77
Industry PE Fwd	48.15
Isin	INE025R01021
Last refreshed	2026-09-12
Market cap	INR 54.6B
Price	INR 346
Price currency	INR
Rev Per Employee	5,419,002.43x
Sector	Healthcare
Sector PE	47.89
Sector PE Fwd	38.25
Sic	8062
Symbol	nse/ARTEMISMED
Website	https://www.artemishospitals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.08%
EV Earnings	50.1x
EV/EBIT	36.6x
EV/EBITDA	28.16x
EV/FCF	210.89x
EV/Sales	5.11x
FCF yield	0.49%
Forward P/E	37.54x
P/B ratio	5.8x
P/E ratio	47.99x
P/S ratio	4.9x
PE Ratio3 Y	45.4x
PE Ratio5 Y	36.26x
PEG ratio	1.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.97%
EBITDA Margin	17.72%
FCF margin	2.5%
Gross margin	22.91%
Gross Profit	INR 2.6B
Gross Profit Growth	25.28%
Gross Profit Growth Q	29.4%
Gross Profit Growth3 Y	19.39%
Gross Profit Growth5 Y	3%
Net Income	INR 1.1B
Net Income Growth	30.28%
Net Income Growth Q	47.14%
Net Income Growth Qo Q	4.26%
Net Income Growth Quarters	13%
Net Income Growth Years	5%
Net Income Growth3 Y	41.64%
Net Income Growth5 Y	38.8%
Pretax Margin	13.65%
Profit Margin	10.21%
Profit Per Employee	INR 553,046
Profitable Quarters	INR 24
Profitable Years	12
Roa5y	5.56
Roe5y	10.95
ROIC	9.98
Roic5y	8.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	44.77%
Cagr3y	36.5%
Cagr5y	56.63%
EPS Growth	30.01
EPS Growth Q	46.67
EPS Growth Qo Q	4.17
EPS Growth Quarters	13
EPS Growth Years	5
EPS Growth3 Y	35.49
EPS Growth5 Y	34.29
FCF Growth	-56.84%
OCF Growth	-15.26%
OCF Growth3 Y	1.24%
OCF Growth5 Y	37.08%
Revenue Growth	14.96x
Revenue Growth Q	12.69x
Revenue Growth Qo Q	2.9x
Revenue Growth Quarters	21x
Revenue Growth Years	5x
Revenue Growth3 Y	12.61x
Revenue Growth5 Y	18.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 334.1M
Debt	INR 2.6B
Debt EBITDA	INR 1.29
Debt Equity	INR 0.28
Debt FCF	INR 9.69
Equity	INR 9.4B
Interest Coverage	6.61
Net Cash	INR -2.3B
Net Cash By Market Cap	INR -4.18
Net Debt EBITDA	INR 1.16
Net Debt Equity	INR 0.24
Net Debt FCF	INR 8.45
Tangible Book Value	INR 8.8B
Tangible Book Value Per Share	INR 55.64
WACC	6.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.15%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.45
Dividend Years	4
Dividend Yield	0.14%
Ex Div Date	2026-07-10
Last Dividend	INR 0.45
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	44.73%
200-day SMA	265.4
3Y total return	154.38%
50-day SMA	304.7
50-day SMA vs 200-day SMA	50over200
5Y total return	842.26%
All Time High	362
All Time High Change	-5.41%
All Time High Date	2026-09-10
All Time Low	10.67
All Time Low Change	3,109%
All Time Low Date	2020-03-24
ATR	12.19
Beta	0.32
Beta1y	0.44
Beta2y	0.28
Ch YTD	26.32
High	351.8
High52	362
High52 Date	2026-09-10
High52ch	-4.5%
Low	339.7
Low52	203.4
Low52 Date	2026-03-30
Low52ch	70%
Ma50ch	12.39%
Price vs 200-day SMA	28.99%
RSI	62.78
RSI Monthly	65.37
RSI Weekly	72.93
Sharpe ratio	1.22x
Sharpe Ratio3y	0.95x
Sharpe Ratio5y	1.19x
Sortino ratio	2.13
Sortino Ratio3y	1.68
Sortino Ratio5y	2.17
Total Return	-0.01%
Tr YTD	26.54
Tr1m	8.37%
Tr1w	2.89%
Tr3m	32.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,294,630%
Net Borrowing	-166,079,000
Shares Insiders	3.08%
Shares Institutions	1.5%
Shares Out	158,306,247
Shares Qo Q	0.08%
Shares Yo Y	0.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	417,374.9x
Bv Per Share	59.04
CAPEX	INR -1B
Ch1m	8.37
Ch1w	2.89
Ch1y	44.49
Ch3m	32.59
Ch3y	152.9
Ch5y	833.2
Ch6m	48.99
Change	-0.82%
Change From Open	-0.82
Close	348.6
Days Gap	0
Depreciation Amortization	417,407,000
Dollar Volume	119,987,630.2
Earnings Date	2026-11-06
EBIT	INR 1.6B
EBITDA	INR 2B
EPS	INR 7.19
F Score	4
FCF	INR 270M
FCF EV Yield	0.47x
FCF Per Share	INR 1.71
Financing CF	-501,013,000
Fiscal Year End	March
Founded	2,004
Graham Number	97.71174
Graham Upside	-71.74
Income Tax	INR 380.6M
Investing CF	-900,296,000
Is Primary Listing	1
Last Earnings Date	2026-08-03
Last Report Date	2026-06-30
Last Split Date	2021-09-23
Last Split Type	Forward
Lynch Fair Value	INR 180
Lynch Upside	-48.03
Ma150	265.8
Ma150ch	28.83%
Ma20	327.5
Ma20ch	4.55%
Net CF	-81,835,000
Next Earnings Date	2026-11-06
Open	348.6
P FCF Ratio	202.2
P OCF Ratio	41.38
Payment Date	2026-08-30
Position In Range	49.59
Price Date	2026-09-11
Price EBITDA	INR 27.67
Ptbv Ratio	6.2
Relative Volume	0.83x
Revenue	11,136,050,000x
Tax By Revenue	3.42x
Tax Rate	25.04%
Tr6m	49.24%
Volume	347,086

NSE/ARTEMISMED (NSE/ARTEMISMED)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/ARTEMISMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/ARTEMISMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/ARTEMISMED

Frequently asked questions